PANCHAKARMA SESSION INTENSITY AND CLINICAL OUTCOMES IN TYPE 2 DIABETES: A DOSE-INTENSITY ANALYSIS ACROSS THREE PK SESSION TIERS IN AN OLDER URBAN COHORT — A RETROSPECTIVE STUDY FROM GOREGAON EAST, MUMBAI

Background: Panchakarma-based Ayurvedic interventions for type 2 diabetes mellitus (T2DM) are delivered in care plans comprising a defined number of sessions — typically 8, 12, 16, or 20+ Panchakarma (PK) administrations. While single-care-plan outcomes have been reported, the dose-response relationship between PK session intensity and clinical outcomes — specifically whether more sessions produce proportionally greater glycemic, hemodynamic, and autonomic improvement — has not been formally examined. This study addresses that gap. Objectives: To evaluate the relationship between the number of Panchakarma sessions completed and clinical outcomes (HbA1c, RBS, heart rate, SBP, and weight) in T2DM patients; and to compare outcomes across three PK intensity tiers: Low (1–8 sessions), Mid (9–14 sessions), and High (15–22 sessions). Methods: Retrospective observational study of 35 T2DM patients treated at Madhavbaug Clinics, Goregaon East, Mumbai. All patients received the CDC-SP protocol: Snehan (Neem Siddha Taila Abhyanga), Swedan (Dashmula Kwath), and Kwath-based Basti (Gudmar, Daru Haridra, Yashti Madhu), alongside the Prameha diet (800 kcal/day) and individualized herbal medication. The number of PK sessions completed (DonePK, range 1–22) was used as the dose-intensity variable. Patients were grouped into Low (n=11, mean 5.8 sessions), Mid (n=18, mean 11.8 sessions), and High (n=10, mean 18.8 sessions) intensity tiers. Pearson correlations and paired t-tests were used. Results: Across the full cohort, all eight clinical parameters improved significantly (all p<0.05): HbA1c Δ −1.13% (p<0.001), RBS Δ −80.4 mg/dL (p<0.001), SBP Δ −12.2 mmHg (p<0.001), DBP Δ −5.4 mmHg (p<0.001), HR Δ −8.5 bpm (p<0.001), weight Δ −4.2 kg (p<0.001). PK sessions completed correlated significantly with RBS change (r=−0.574, p=0.0006) and HR change (r=−0.561, p=0.0008), with a trend for HbA1c (r=−0.316, p=0.101). Tier analysis revealed a clear dose-response: the High-intensity group (15–22 sessions) showed significantly greater improvements than Low (1–8 sessions) in RBS (Δ −149.1 vs. −38.4 mg/dL), HR (Δ −14.2 vs. −1.2 bpm), SBP (Δ −20.9 vs. −10.2 mmHg), and HbA1c (Δ −1.6 vs. −0.4%). The Mid group showed intermediate outcomes, confirming a stepwise dose-response across all three tiers. SBP ≥160 mmHg was eliminated from the cohort (4→0 patients); 64.3% of diastolic hypertensives normalized DBP to <90 mmHg. Two patients with concurrent CHF, IHD, and CAD showed meaningful cardiometabolic improvement with no adverse events. Conclusion: PK session intensity is significantly and independently correlated with clinical outcomes in T2DM, particularly for blood glucose and heart rate reduction. The dose-response relationship supports a biological model where more intensive Panchakarma — through greater cumulative berberine and gymnemic acid colonic exposure, sustained dietary engagement, and progressive autonomic restoration — produces proportionally superior glycemic and cardiovascular benefits. These findings provide preliminary evidence that prescribing PK intensity according to disease severity may optimize outcomes in T2DM management.

• Hill AB. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 1965; 58(5): 295–300.
• Yin J, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine, 2004; 10(12): 1344–1351.
• Baskaran K, et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre. Journal of Ethnopharmacology, 1990; 30(3): 295–300.
• Eu CH, et al. Glycyrrhizic acid improved lipoprotein lipase expression, insulin sensitivity and serum lipid levels. Lipids in Health and Disease, 2010; 9: 81.
• American Diabetes Association. Standards of Medical Care in Diabetes — 2023. Diabetes Care, 2023; 46(Supplement 1).
• Vinik AI, et al. Diabetic autonomic neuropathy. Diabetes Care, 2003; 26(5): 1553–1579.
• Rapaport MH, et al. Modification of Swedish massage context affects heart rate variability. Journal of Alternative and Complementary Medicine, 2012; 18(4): 360–367.
• Bonaz B, et al. The vagus nerve at the interface of the microbiota-gut-brain axis. Frontiers in Neuroscience, 2018; 12: 49.
• Lean MEJ, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT). Lancet, 2018; 391(10120): 541–551.
• Mohan V, et al. Epidemiology of type 2 diabetes: Indian scenario. Indian Journal of Medical Research, 2007; 125(3): 217–230.